Agios Pharmaceuticals Inc (NASDAQ: AGIO) kicked off on Monday, down -3.07% from the previous trading day, before settling in for the closing price of $28.02. Over the past 52 weeks, AGIO has traded in a range of $22.24-$46.00.
While this was happening, its average annual earnings per share was recorded -160.69%. With a float of $54.95 million, this company’s outstanding shares have now reached $58.28 million.
Agios Pharmaceuticals Inc (AGIO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Agios Pharmaceuticals Inc is 5.77%, while institutional ownership is 101.98%. The most recent insider transaction that took place on Nov 12 ’25, was worth 8,768. In this transaction Director of this company sold 200 shares at a rate of $43.84, taking the stock ownership to the 17,603 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Chief Medical Officer sold 2,454 for $43.78, making the entire transaction worth $107,436. This insider now owns 61,727 shares in total.
Agios Pharmaceuticals Inc (AGIO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.74 earnings per share (EPS), lower than consensus estimate (set at -1.63) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -160.69% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Take a look at Agios Pharmaceuticals Inc’s (AGIO) current performance indicators. Last quarter, stock had a quick ratio of 13.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 35.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.96, a number that is poised to hit -1.95 in the next quarter and is forecasted to reach -6.48 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals Inc (NASDAQ: AGIO) saw its 5-day average volume 2.5 million, a positive change from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 67.29%.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 20.71%, which indicates a significant decrease from 51.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.24 in the past 14 days, which was lower than the 1.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.98, while its 200-day Moving Average is $34.25. Nevertheless, the first resistance level for the watch stands at $27.76 in the near term. At $28.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $28.71. If the price goes on to break the first support level at $26.80, it is likely to go to the next support level at $26.45. Assuming the price breaks the second support level, the third support level stands at $25.85.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
The company with the Market Capitalisation of 1.58 billion has total of 58,314K Shares Outstanding. Its annual sales at the moment are 36,500 K in contrast with the sum of 673,730 K annual income. Company’s last quarter sales were recorded 12,880 K and last quarter income was -103,430 K.
